vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Intellicheck, Inc. (IDN). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $6.6M, roughly 1.4× Intellicheck, Inc.). Intellicheck, Inc. runs the higher net margin — 23.4% vs -234.3%, a 257.7% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 11.8%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 19.1%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Intellicheck, Inc. is a US-based technology company specializing in identity verification and fraud prevention solutions. It develops AI-powered tools to validate government-issued identification documents, streamline customer onboarding, and mitigate identity theft risks for clients across finance, retail, healthcare and public sector segments.
FHTX vs IDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $6.6M |
| Net Profit | $-21.7M | $1.6M |
| Gross Margin | — | 91.4% |
| Operating Margin | -258.2% | 22.5% |
| Net Margin | -234.3% | 23.4% |
| Revenue YoY | 223.8% | 11.8% |
| Net Profit YoY | -11.1% | 218.0% |
| EPS (diluted) | $-0.35 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $6.6M | ||
| Q3 25 | $8.2M | $6.0M | ||
| Q2 25 | $7.6M | $5.1M | ||
| Q1 25 | $6.0M | $4.9M | ||
| Q4 24 | $2.9M | $5.9M | ||
| Q3 24 | $7.8M | $4.7M | ||
| Q2 24 | $6.9M | $4.7M | ||
| Q1 24 | $5.0M | $4.7M |
| Q4 25 | $-21.7M | $1.6M | ||
| Q3 25 | $-15.8M | $290.0K | ||
| Q2 25 | $-17.9M | $-251.0K | ||
| Q1 25 | $-18.8M | $-318.0K | ||
| Q4 24 | $-19.5M | $488.0K | ||
| Q3 24 | $-19.1M | $-837.0K | ||
| Q2 24 | $-23.0M | $-127.0K | ||
| Q1 24 | $-25.0M | $-442.0K |
| Q4 25 | — | 91.4% | ||
| Q3 25 | — | 90.5% | ||
| Q2 25 | — | 89.8% | ||
| Q1 25 | — | 89.7% | ||
| Q4 24 | — | 91.1% | ||
| Q3 24 | — | 91.0% | ||
| Q2 24 | — | 90.5% | ||
| Q1 24 | — | 90.7% |
| Q4 25 | -258.2% | 22.5% | ||
| Q3 25 | -226.9% | 4.0% | ||
| Q2 25 | -279.2% | -5.8% | ||
| Q1 25 | -385.0% | -7.1% | ||
| Q4 24 | -840.5% | 8.1% | ||
| Q3 24 | -305.5% | -19.3% | ||
| Q2 24 | -386.6% | -4.6% | ||
| Q1 24 | -558.3% | -11.2% |
| Q4 25 | -234.3% | 23.4% | ||
| Q3 25 | -194.4% | 4.8% | ||
| Q2 25 | -237.3% | -4.9% | ||
| Q1 25 | -316.4% | -6.5% | ||
| Q4 24 | -682.9% | 8.2% | ||
| Q3 24 | -244.9% | -17.8% | ||
| Q2 24 | -333.6% | -2.7% | ||
| Q1 24 | -495.4% | -9.4% |
| Q4 25 | $-0.35 | $0.08 | ||
| Q3 25 | $-0.25 | $0.01 | ||
| Q2 25 | $-0.28 | $-0.01 | ||
| Q1 25 | $-0.30 | $-0.02 | ||
| Q4 24 | $-0.23 | $0.02 | ||
| Q3 24 | $-0.31 | $-0.04 | ||
| Q2 24 | $-0.45 | $-0.01 | ||
| Q1 24 | $-0.59 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $9.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $20.7M |
| Total Assets | $198.1M | $24.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $9.7M | ||
| Q3 25 | $89.3M | $7.2M | ||
| Q2 25 | $72.6M | $8.6M | ||
| Q1 25 | $61.0M | $5.1M | ||
| Q4 24 | $55.5M | $4.7M | ||
| Q3 24 | $57.7M | $5.7M | ||
| Q2 24 | $138.9M | $7.3M | ||
| Q1 24 | $79.3M | $9.2M |
| Q4 25 | $-108.5M | $20.7M | ||
| Q3 25 | $-89.7M | $18.9M | ||
| Q2 25 | $-76.7M | $18.0M | ||
| Q1 25 | $-61.7M | $17.6M | ||
| Q4 24 | $-45.5M | $17.7M | ||
| Q3 24 | $-28.3M | $16.7M | ||
| Q2 24 | $-14.3M | $17.3M | ||
| Q1 24 | $-97.5M | $17.2M |
| Q4 25 | $198.1M | $24.5M | ||
| Q3 25 | $205.0M | $25.3M | ||
| Q2 25 | $226.2M | $23.1M | ||
| Q1 25 | $258.7M | $24.6M | ||
| Q4 24 | $284.0M | $20.9M | ||
| Q3 24 | $308.4M | $20.7M | ||
| Q2 24 | $328.6M | $21.9M | ||
| Q1 24 | $255.0M | $22.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $2.4M |
| Free Cash FlowOCF − Capex | — | $2.4M |
| FCF MarginFCF / Revenue | — | 36.0% |
| Capex IntensityCapex / Revenue | 0.0% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.54× |
| TTM Free Cash FlowTrailing 4 quarters | — | $4.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $2.4M | ||
| Q3 25 | $-18.9M | $-1.7M | ||
| Q2 25 | $-21.0M | $3.1M | ||
| Q1 25 | $-24.0M | $750.0K | ||
| Q4 24 | $-24.5M | $-1.3M | ||
| Q3 24 | $-21.0M | $-1.1M | ||
| Q2 24 | $-25.5M | $-1.2M | ||
| Q1 24 | $-29.3M | $869.0K |
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $-1.8M | ||
| Q2 25 | $-21.0M | $3.1M | ||
| Q1 25 | $-24.0M | $741.0K | ||
| Q4 24 | $-25.0M | $-1.3M | ||
| Q3 24 | $-21.3M | $-1.1M | ||
| Q2 24 | $-25.6M | $-1.2M | ||
| Q1 24 | $-29.4M | $860.0K |
| Q4 25 | — | 36.0% | ||
| Q3 25 | — | -29.2% | ||
| Q2 25 | -278.2% | 60.9% | ||
| Q1 25 | -403.2% | 15.1% | ||
| Q4 24 | -875.3% | -22.4% | ||
| Q3 24 | -273.0% | -23.1% | ||
| Q2 24 | -371.0% | -25.5% | ||
| Q1 24 | -583.1% | 18.4% |
| Q4 25 | 0.0% | 0.1% | ||
| Q3 25 | 0.0% | 0.4% | ||
| Q2 25 | 0.3% | 0.3% | ||
| Q1 25 | 0.5% | 0.2% | ||
| Q4 24 | 16.8% | 0.2% | ||
| Q3 24 | 4.0% | 0.6% | ||
| Q2 24 | 0.2% | 0.2% | ||
| Q1 24 | 2.0% | 0.2% |
| Q4 25 | — | 1.54× | ||
| Q3 25 | — | -5.99× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.71× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
